2024
Characterization of time toxicity in older patients with metastatic breast cancer
Atre S, Soulos P, Kuderer N, Gross C, Baum L, Dinan M, Lustberg M. Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Research And Treatment 2024, 207: 541-550. PMID: 38816556, DOI: 10.1007/s10549-024-07379-7.Peer-Reviewed Original ResearchMetastatic breast cancerBone-modifying agentsComorbid medical conditionsOlder patientsBreast cancerRetrospective cohort studySEER-Medicare databaseTreatment typeCancer treatment modalityTreatment modalitiesSEER-MedicareCohort studyUnadjusted analysisPatientsAge-related impactCancer treatmentComorbiditiesDay patientsCancerRadiotherapyOlder ageMedical conditionsToxicityTreatmentSociodemographic factors
2023
Clinician and Cancer Survivor Perspectives on Managing Chronic Pain after Cancer Treatment: A Qualitative Study (Sci216)
Check D, O'Regan A, Jones K, Fish L, Dinan M, Farley S, E. J, Makarushka C, Merlin J, Somers T, Oeffinger K. Clinician and Cancer Survivor Perspectives on Managing Chronic Pain after Cancer Treatment: A Qualitative Study (Sci216). Journal Of Pain And Symptom Management 2023, 65: e648. DOI: 10.1016/j.jpainsymman.2023.02.266.Peer-Reviewed Original ResearchChronic painPalliative care cliniciansCancer survivorsCare cliniciansCancer treatmentCancer survivorshipLong-term opioid therapyRoutine survivorship careCurative-intent treatmentActive cancer treatmentChronic pain managementImpact of painCancer survivors' perspectivesOpioid therapySurvivorship carePain managementActive treatmentMultimodal managementPain carePrimary careHigh prevalencePainCliniciansSurvivorsSurvivors' perspectivesClinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer Treatment
Check D, Jones K, Fish L, Dinan M, Dunbar T, Farley S, Ma J, Merlin J, O'Regan A, Oeffinger K. Clinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer Treatment. JCO Oncology Practice 2023, 19: e484-e491. PMID: 36595729, PMCID: PMC10530392, DOI: 10.1200/op.22.00410.Peer-Reviewed Original ResearchConceptsChronic painCancer survivorsClinician experienceLong-term opioid therapyMultimodal pain careCurative-intent treatmentBehavioral health servicesAcademic medical centerOpioid therapyOpioid managementActive treatmentPain careHighlights unmetHigh prevalenceClinician's perspectiveMedical CenterMost cliniciansPainMultidisciplinary teamHealth servicesPsychosocial stressorsPain monitoringCliniciansCancer treatmentSurvivors
2022
Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma
Miller SM, Wilson LE, Greiner MA, Pritchard JE, Zhang T, Kaye DR, Cohen HJ, Becher RD, Maerz LL, Dinan MA. Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma. Journal Of Geriatric Oncology 2022, 13: 635-643. PMID: 34996724, PMCID: PMC9232862, DOI: 10.1016/j.jgo.2021.12.012.Peer-Reviewed Original ResearchConceptsMetastatic renal cell carcinomaNon-cancer controlsRenal cell carcinomaMRCC diagnosisMild cognitive impairmentCell carcinomaRisk factorsCognitive impairmentOlder adultsProportional hazards modelNew cancer treatmentsCohort entryOlder patientsSurgical therapyMAIN OUTCOMEExclusion criteriaAgent useDisease processHazards modelPatientsMedicare datasetCancer treatmentDiagnosisDementiaCarcinoma